These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21999607)

  • 1. Systematic review: the role of tacrolimus in the management of Crohn's disease.
    McSharry K; Dalzell AM; Leiper K; El-Matary W
    Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1282-94. PubMed ID: 21999607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate for maintenance of remission in Crohn's disease.
    Patel V; Macdonald JK; McDonald JW; Chande N
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006884. PubMed ID: 19821390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003459. PubMed ID: 15674908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine for induction of remission in Crohn's disease.
    McDonald JW; Feagan BG; Jewell D; Brynskov J; Stange EF; Macdonald JK
    Cochrane Database Syst Rev; 2005 Apr; (2):CD000297. PubMed ID: 15846602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2003; (1):CD003459. PubMed ID: 12535475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natalizumab for induction of remission in Crohn's disease.
    Macdonald JK; McDonald JW
    Cochrane Database Syst Rev; 2006 Jul; (3):CD006097. PubMed ID: 16856112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natalizumab for induction of remission in Crohn's disease.
    MacDonald JK; McDonald JW
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006097. PubMed ID: 17253580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
    Behm BW; Bickston SJ
    Cochrane Database Syst Rev; 2008 Jan; (1):CD006893. PubMed ID: 18254120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide and thalidomide analogues for induction of remission in Crohn's disease.
    Srinivasan R; Akobeng AK
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007350. PubMed ID: 19370684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical tacrolimus in the treatment of perianal Crohn's disease: exploratory randomized controlled trial.
    Hart AL; Plamondon S; Kamm MA
    Inflamm Bowel Dis; 2007 Mar; 13(3):245-53. PubMed ID: 17206671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminosalicylates for induction of remission or response in Crohn's disease.
    Lim WC; Hanauer S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008870. PubMed ID: 21154400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease.
    Sandborn WJ
    Am J Gastroenterol; 1997 May; 92(5):876-9. PubMed ID: 9149205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteral nutritional therapy for inducing remission of Crohn's disease.
    Zachos M; Tondeur M; Griffiths AM
    Cochrane Database Syst Rev; 2001; (3):CD000542. PubMed ID: 11686966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease.
    Casson DH; Eltumi M; Tomlin S; Walker-Smith JA; Murch SH
    Gut; 2000 Sep; 47(3):436-40. PubMed ID: 10940284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Adalimumab for Paediatric Crohn's Disease: A Systematic Review.
    Dziechciarz P; Horvath A; KierkuĊ› J
    J Crohns Colitis; 2016 Oct; 10(10):1237-44. PubMed ID: 26995184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial.
    Sandborn WJ; Present DH; Isaacs KL; Wolf DC; Greenberg E; Hanauer SB; Feagan BG; Mayer L; Johnson T; Galanko J; Martin C; Sandler RS
    Gastroenterology; 2003 Aug; 125(2):380-8. PubMed ID: 12891539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse rate following azathioprine withdrawal in maintaining remission for Crohn's disease: a meta-analysis.
    French H; Mark Dalzell A; Srinivasan R; El-Matary W
    Dig Dis Sci; 2011 Jul; 56(7):1929-36. PubMed ID: 21476031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K; Ludwig D; Stahl M; David-Walek T; Stange EF
    Am J Gastroenterol; 1998 Oct; 93(10):1860-6. PubMed ID: 9772045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus for Crohn's disease.
    Ruddock B
    Issues Emerg Health Technol; 2006 Sep; (88):1-4. PubMed ID: 16981314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Efficacy and Adverse Events of Tacrolimus in Patients with Crohn's Disease: Systematic Review and Meta-Analysis.
    Iida T; Nojima M; Nakase H
    Dig Dis Sci; 2019 Oct; 64(10):2945-2954. PubMed ID: 30982208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.